STipe Therapeutics
About:
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Website: http://www.stipetherapeutics.com/
Top Investors: Novo Holdings, Wellington Partners, BioInnovation Institute, Arix Bioscience, Life Science Venture Capital Management
Description:
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compounds that sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response.
20M EUR
$1M to $10M
Aarhus, Midtjylland, Denmark
2018-01-01
Claus Elsborg Olesen, Martin Roelsgaard Jakobsen
11-50
2019-09-30
Private
© 2025 bioDAO.ai